P-ISSN 2587-2400 | E-ISSN 2587-196X
EJMO Sponsors
- Amgen
- Roche
- Astellas
- AstraZeneca
- Bristol-Myers Squibb
- Johnson Johnson
- Merck
- Pfizer
- Novartis
- Omnigen
- Mustafa Nevzat
- Arven
- TEVA
- Trpharm
The Molecular Docking Study of Potential Drug Candidates Showing Anti-COVID-19 Activity by Exploring of Therapeutic Targets of SARS-CoV-2